hydroxychloroquine has been researched along with Phlegmasia Alba Dolens in 23 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Phlegmasia Alba Dolens: Inflammation that is characterized by swollen, pale, and painful limb. It is usually caused by DEEP VEIN THROMBOSIS in a FEMORAL VEIN, following PARTURITION or an illness. This condition is also called milk leg or white leg.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Evidence for the usefulness of hydroxychloroquine as prophylaxis against thromboembolism after total hip replacement is examined." | 8.77 | Hydroxychloroquine and postoperative thromboembolism after total hip replacement. ( Loudon, JR, 1988) |
| "Evidence for the usefulness of hydroxychloroquine as prophylaxis against thromboembolism after total hip replacement is examined." | 4.77 | Hydroxychloroquine and postoperative thromboembolism after total hip replacement. ( Loudon, JR, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (91.30) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BETETTO, D | 1 |
| CRISTINA, P | 1 |
| SPANIO, G | 1 |
| Bouchier-Hayes, D | 1 |
| Verstraete, M | 1 |
| Johansson, E | 1 |
| Forsberg, K | 1 |
| Johnsson, H | 1 |
| Van Horn, G | 1 |
| Arnett, FC | 1 |
| Dimachkie, MM | 1 |
| Paiement, GD | 1 |
| Hume, M | 2 |
| Bierbaum, B | 1 |
| Kuriakose, TX | 2 |
| Surprenant, J | 2 |
| Wu, TK | 1 |
| Tsapogas, MJ | 1 |
| Jordan, FR | 1 |
| Kher, A | 1 |
| Toulemonde, F | 1 |
| Turpie, AG | 1 |
| Hirsh, J | 3 |
| Sasahara, AA | 1 |
| Sharma, GV | 1 |
| Parisi, AF | 1 |
| Uhl, JF | 1 |
| Huguier, M | 1 |
| Gallus, AS | 1 |
| Chrisman, OD | 1 |
| Snook, GA | 1 |
| Wilson, TC | 1 |
| Short, JY | 1 |
| Turner, RH | 1 |
| Hansen, EH | 1 |
| Jessing, P | 1 |
| Lindewald, H | 1 |
| Ostergaard, P | 1 |
| Olesen, T | 1 |
| Malver, EI | 1 |
| Joffe, SN | 1 |
| Genton, E | 1 |
| Gent, M | 1 |
| Harker, LA | 1 |
| Pilcher, DB | 1 |
| Loudon, JR | 1 |
| Didisheim, P | 1 |
| Kazmier, FJ | 1 |
| Fuster, V | 1 |
| Bounameaux, Y | 1 |
| Carter, AE | 1 |
| Eban, R | 1 |
10 reviews available for hydroxychloroquine and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
Mechanical prophylaxis and other modalities.
Topics: Antithrombin III; Bandages; Dextrans; Forecasting; Hip Prosthesis; Humans; Hydroxychloroquine; Motio | 1992 |
[Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin].
Topics: Anticoagulants; Dextrans; Dipyridamole; Femoral Neck Fractures; Heparin; Hip Joint; Humans; Hydroxyc | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
New developments in the detection and prevention of venous thromboembolism.
Topics: Aspirin; Clothing; Dextrans; Electric Stimulation Therapy; Fibrinolytic Agents; Heparin; Hip Joint; | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; He | 1979 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibr | 1976 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
Hydroxychloroquine and postoperative thromboembolism after total hip replacement.
Topics: Biomechanical Phenomena; Hip Prosthesis; Humans; Hydroxychloroquine; Pulmonary Embolism; Thromboembo | 1988 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
8 trials available for hydroxychloroquine and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement.
Topics: Adult; Aged; Blood Coagulation; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; | 1981 |
Prevention of postoperative thrombosis by aspirin.
Topics: Aspirin; Clinical Trials as Topic; Drug Evaluation; Hip Joint; Humans; Hydroxychloroquine; Joint Pro | 1977 |
Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Fibrinogen; Heparin; Humans; Hyd | 1977 |
Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report.
Topics: Adult; Aged; Clinical Trials as Topic; Fractures, Bone; Humans; Hydroxychloroquine; Leg; Middle Aged | 1976 |
Hydroxychloroquine sulphate in prevention of deep venous thrombosis following fracture of the hip, pelvis, or thoracolumbar spine.
Topics: Aged; Female; Fibrinogen; Fractures, Bone; Hip Injuries; Humans; Hydroxychloroquine; Lumbar Vertebra | 1976 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate.
Topics: Administration, Oral; Aged; Female; Fibrinogen; Humans; Hydroxychloroquine; Iodine Radioisotopes; Le | 1974 |
6 other studies available for hydroxychloroquine and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
[THE USE OF HYDROXYCHLOROQUINE IN THE TREATMENT OF VASCULAR DISEASES].
Topics: Arteriosclerosis; Arteritis; Blood Proteins; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hydr | 1963 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc | 1983 |
Reversible dementia and chorea in a young woman with the lupus anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Chorea; Dementia; Depression; Diagno | 1996 |
Venous thrombosis after total hip replacement. Combined monitoring as a guide for prophylaxis and treatment.
Topics: Arthroplasty; Blood Platelets; Hip Joint; Humans; Hydroxychloroquine; Joint Prosthesis; Plethysmogra | 1976 |
Hydroxychloroquine sulfate in prevention of thromboembolic phenomena in surgical patients.
Topics: Hematocrit; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Surgical | 1975 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thromboph | 1973 |